HealthStream (HSTM)
(Delayed Data from NSDQ)
$29.00 USD
-0.17 (-0.58%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $29.02 +0.02 (0.07%) 6:40 PM ET
2-Buy of 5 2
C Value C Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
HSTM 29.00 -0.17(-0.58%)
Will HSTM be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for HSTM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HSTM
Akamai and LevelBlue Launch Managed Web App, API Protection Services
HealthStream (HSTM) Surpasses Q2 Earnings Estimates
HSTM: What are Zacks experts saying now?
Zacks Private Portfolio Services
OPRX Delivers Solid Q1 Earnings: But Can It Sustain the Momentum?
OptimizeRx Bets on AI and Workflow Integration: Will This Pay Off?
Does DOCS' Shift Toward Enterprise Offerings Signal a Long-Term Pivot?
Other News for HSTM
Doji - Bearish? appears for HSTM after 0.59% move
HSTM traded flat on September 18, leaving the technical picture intact
Sideways movement on September 16 results in no shift to HSTM’s technical outlook
HSTM forms New Uptrend on September 15
Stochastic Sell Signal appears for HSTM after 1.23% move